FANCI is a negative regulator of Akt activation

Area of Science:

• Cellular Biology
• Molecular Oncology
• Signal Transduction

Background:

• The PI3K-Akt pathway is a key regulator of cell growth and survival, frequently dysregulated in cancer.
• Akt activation is tightly controlled by opposing kinases and phosphatases.
• The Fanconi anemia (FA) pathway is primarily known for its role in DNA repair.

Purpose of the Study:

• To investigate the regulatory mechanisms of Akt activation.
• To identify novel protein complexes involved in Akt signaling.
• To explore potential intersections between the PI3K-Akt and FA pathways.

Main Methods:

• Co-immunoprecipitation assays to identify protein complex composition.
• Western blotting to assess protein phosphorylation and activation.
• RNA interference (siRNA) to deplete specific proteins (FANCI, FANCD2, USP1).
• Assessment of apoptosis following DNA damage.

Main Results:

• A novel protein complex including Akt, PHLPP1, PHLPP2, FANCI, FANCD2, USP1, and UAF1 was identified.
• Depletion of FANCI, but not FANCD2 or USP1, led to increased Akt phosphorylation and activation.
• FANCI depletion reduced the interaction between PHLPP1 and Akt.
• Interactions between Akt, PHLPP1, and FANCI decreased upon DNA damage or growth factor stimulation.
• FANCI depletion resulted in reduced apoptosis after DNA damage.

Conclusions:

• FANCI plays a previously unrecognized role as a negative regulator of Akt activation.
• The FA pathway protein FANCI modulates Akt activity by influencing the PHLPP1-Akt interaction.
• This study reveals a novel intersection between the PI3K-Akt and FA pathways with implications for cancer biology.